Unlock instant, AI-driven research and patent intelligence for your innovation.

Innovative discovery of therapeutic, diagnostic and antibody compositions related to protein fragments of glutaminyl-tRNA synthetase

A therapeutic composition, technology of synthesizing enzymes, applied in the field of polynucleotides and their complements

Active Publication Date: 2017-07-18
ATYR PHARM INC +1
View PDF269 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Likewise, no systematic experimental analyzes have been performed to examine the use of such resectins as biotherapeutics, diagnostics, or drug targets in the treatment of various medical conditions, or their potential association with human disease

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Innovative discovery of therapeutic, diagnostic and antibody compositions related to protein fragments of glutaminyl-tRNA synthetase
  • Innovative discovery of therapeutic, diagnostic and antibody compositions related to protein fragments of glutaminyl-tRNA synthetase
  • Innovative discovery of therapeutic, diagnostic and antibody compositions related to protein fragments of glutaminyl-tRNA synthetase

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 217

[0074] I. Overview

[0075] The present invention relates at least in part to the discovery of novel AARS polypeptides, and methods for their preparation and use, which represent the conversion of a native wild-type protein into a new species exhibiting significantly different properties compared to the naturally occurring full-length glutaminyl tRNA synthetase gene. form. The identification of such AARS polypeptides was based on extensive sequence and mass spectrometric analysis of glutaminyl tRNA synthetases expressed in different tissues, followed by systematic generation and testing of each potential AARS polypeptide to identify those representing stable and soluble protein domains. Protein sequences that exhibit novel biological activities and favorable therapeutic drug properties.

[0076] Based on this analysis, several new families of AARS polypeptides derived from glutaminyl tRNA synthetases have been identified.

[0077] In one aspect, such glutaminyl tRNA syntheta...

Embodiment 1

[0772] Identification of proteolytic fragments and alternative splicing products from AARS using a protein topology and migration analysis platform

[0773] To identify AARS fragments from cell lines, conditioned media, and tissues, prepare samples as follows:

[0774] Mouse macrophages (RAW 264.7), cytosol and conditioned media: Use 15x 10 in serum-free DMEM 6 Density of cells / flask Treat cells. After 48 hours, conditioned media and cell pellets were collected and processed. 200 μg of protein were separated by SDS-PAGE from secretory and cytosolic proteome fractions, and gel slices were prepared for analysis by mass spectrometry.

[0775] Mouse pancreas tissue: Pancreas were dissected from three mice, dounce homogenized, and sonicated in PBS containing protease inhibitors. The cytosolic proteome was separated by centrifugation and 200 μg of protein was separated by SDS-PAGE and gel slices were prepared for analysis by mass spectrometry.

[0776] Mouse liver tissue: livers...

Embodiment 2

[0781] Identifying splice variants using deep sequencing

[0782] Identification of splice variants of aminoacyl tRNA synthetases using high-throughput sequencing of cDNA libraries enriched for aminoacyl tRNA synthetase transcripts. Prepare cDNA templates from total RNA extracts of tissues such as adult and fetal brain and enrich for aminoacyl-tRNA synthesis using primer sequences specific for all annotated exons of all annotated human aminoacyl-tRNA synthetases and their associated proteins Enzyme transcripts.

[0783] Human total RNA was obtained from Clontech. For cell lines and mouse tissue samples, total RNA was extracted using the RNA Extraction II Kit (MN). Genomic DNA in total RNA samples was digested by DNase I. To obtain mature messenger RNA (mRNA), RNA samples were enriched twice by incorporation of poly-A+ RNA and by digestion of 5'-capped RNA by a 5'-phosphate-dependent exonuclease. Complementary DNA (cDNA) is synthesized from mature RNA using primers that ann...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
solubility (mass)aaaaaaaaaa
particle sizeaaaaaaaaaa
molecular weightaaaaaaaaaa
Login to View More

Abstract

Provided are compositions comprising newly identified protein fragments of aminoacyl-tRNA synthetases, polynucleotides that encode them and complements thereof, related agents, and methods of use thereof in diagnostic, drug discovery, research, and therapeutic applications.

Description

[0001] Cross References to Related Applications [0002] This application claims U.S. Provisional Patent Application No. 61 / 349,140, ​​filed May 27, 2010, U.S. Provisional Patent Application No. 61 / 349,141, filed May 27, 2010, and The benefit of U.S. Provisional Patent Application No. 61 / 349,143, filed May 27, 2010, each of which is incorporated herein by reference in its entirety. [0003] Statement Regarding Sequence Listing [0004] The Sequence Listing associated with this application is provided in text format instead of hard copy and is hereby incorporated by reference into this specification. The name of the text file containing the sequence listing is 120161_441PC_SEQUENCE_LISTING.txt. This text file is approximately 444KB, was created on May 26, 2011, and was submitted electronically via EFS-Web. technical field [0005] The present invention generally relates to compositions comprising newly identified protein fragments of aminoacyl-tRNA synthetases and other prot...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K38/16A61K38/08A61K38/10A61K39/395A61P35/00A61P3/10A61P29/00
CPCA61K38/00A61P3/00A61P3/10A61P7/00A61P9/00A61P21/00A61P25/00A61P29/00A61P31/00A61P35/00A61P37/02C07K16/40C12N9/93C12Y601/01A61K9/0019C07K2317/24C07K2317/34C07K2317/92G01N33/573G01N2333/9015
Inventor 莱斯利·安·格林尼凯尔·P·基昂格洪非阿兰·P·瓦瑟洛特罗咏诗杰弗里·D·沃特金斯谢丽尔·L·奎恩约翰·D·门德莱恩
Owner ATYR PHARM INC